Mauna Kea Technologies Announces the Appointment of Sacha Loiseau as Chief Executive Officer

Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY), inventor of Cellvizio, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform

Related Keywords

Paris ,France General ,France ,Mauna Kea ,Mauna Kea Technologie ,Nicolas Bouvier ,Christopherd Mcfadden ,Tasly Pharma ,Thomas Grojean ,Mauna Kea Techonologie ,Sacha Loiseau ,Telix Pharmaceuticals ,Johnson ,Remuneration Committee ,Euronext ,Regulatory News ,Kea Technologies ,Mauna Kea Technologies ,Chief Executive Officer ,Mauna Kea Technologies Board ,Board Member ,Target Labs ,Mauna Kea Technologies Chairman ,Seqone Genomics ,Venture Partner ,Deeptech European Venture Capital ,Registration Document ,Universal Registration Document ,Cap Financial ,Mauna ,Technologies ,Nnounces ,Appointment ,Gacha ,Noiseau ,Chief ,Executive ,Officer ,